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Abstract
Vaccinia virus produces two distinct infectious virions; the single-enveloped intracellular mature virus (IMV), which remains
in the cell until cell lysis, and the double-enveloped extracellular enveloped virus (EEV), which mediates virus spread. The
latter is derived from a triple-enveloped intracellular enveloped virus (IEV) precursor, which is transported to the cell
periphery by the kinesin-1 motor complex. This transport involves the viral protein A36 as well as F12 and E2. A36 is an
integral membrane protein associated with the outer virus envelope and is the only known direct link between virion and
kinesin-1 complex. Yet in the absence of A36 virion egress still occurs on microtubules, albeit at reduced efficiency. In this
paper double-fluorescent labelling of the capsid protein A5 and outer-envelope protein F13 was exploited to visualize IEV
transport by live-cell imaging in the absence of either A36 or F12. During the generation of recombinant viruses expressing
both A5-GFP and F13-mCherry a plaque size defect was identified that was particularly severe in viruses lacking A36.
Electron microscopy showed that this phenotype was caused by abnormal wrapping of IMV to form IEV, and this resulted in
reduced virus egress to the cell surface. The aberrant wrapping phenotype suggests that the fluorescent fusion protein
interferes with an interaction of F13 with the IMV surface that is required for tight association between IMVs and wrapping
membranes. The severity of this defect suggests that these viruses are imperfect tools for characterizing virus egress.
INTRODUCTION
The family Poxviridae comprises large DNA viruses that
replicate in the cytoplasm of their host cell [1]. Poxvirus
replication has been studied most extensively using vaccinia
virus (VACV), the prototype member of the family and the
live vaccine used in the eradication of smallpox [2]. During
VACV replication infectious virions known as intracellular
mature virus (IMV) are formed within virus factories [3].
Some IMVs migrate from the viral factories in a microtu-
bule (MT)-dependent manner [4, 5] and are wrapped by a
double envelope derived from trans-Golgi [6] or early endo-
somal [7] membranes. These virions, known as intracellular
enveloped viruses (IEVs), are transported towards the cell
surface (for a review see [8]) along MTs in a kinesin-1-
dependent manner [9–12], where their outer envelope fuses
with the cell membrane. Virions are either released as extra-
cellular enveloped virions (EEVs) or remain attached to the
cell surface as cell-associated enveloped virions (CEV).
Nucleation of actin polymerization underneath CEVs
results in the formation of actin tails projecting virions away
from the cell (reviewed in [13]).
Three VACV proteins, A36, F12 and E2, influence the trans-
port of IEVs by kinesin-1. Viruses lacking A36 [14], F12
[15, 16] or E2 [17] form IEV normally [18], but have defects
in IEV transport to the cell surface. A36 is an integral mem-
brane protein that is enriched in the outer envelope of IEVs
[19] and associates with the kinesin light chain (KLC) com-
ponent of kinesin-1 [20, 21]. Recently, A36 was shown to
bind specifically to KLC isoform 1 and not to KLC2 [22].
Intracellular movement of IEVs at speeds consistent with
MT-mediated trafficking occurs in the absence of A36, albeit
at reduced efficiency and with reduced run lengths, and sur-
face virions are present at 50% of wild-type (WT) levels late
during infection [23]. In addition, A36 is required for F12
association with IEVs [24].
F12 and E2 are cytoplasmic proteins that form a complex
associated with IEVs during egress [25]. The F12/E2 com-
plex associates preferentially with KLC2 via an interaction
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between E2 and the KLC C-terminal tail [26]. Viruses lack-
ing either F12 or E2 display similar phenotypes, resulting in
almost complete loss of IEV egress [18], and the association
of either protein with IEVs is dependent on the other [25].
To study the roles of A36 and the F12/E2 complex in virion
trafficking in greater detail we sought to generate fluores-
cently-labelled viruses that would enable the comparison of
IEV movement in different mutant viruses by live-cell
microscopy. Several viruses containing fluorescent proteins
fused to virion proteins have been reported. Green fluores-
cent protein (GFP) fused to capsid protein A5 (product of
the VACVWR123 open reading frame) was used to visualize
virion movement along MTs following entry [27]. This
A5GFP labels all virions (naked cores, IMVs, IEVs, CEVs
and EEVs) in infected cells. To track the movement of IEVs
and differentiate them from IMVs, several laboratories have
fused fluorescent proteins to either F13 [9, 28] or B5 [10, 29]
that are present in the IEV, CEV and EEV but are absent
from IMV. B5 is a type I transmembrane glycoprotein with
the majority of the protein projecting into the lumen of the
wrapping membranes and exposed on the surface of
the CEV/EEV [30, 31]. F13 is a palmitoylated protein
that is associated with the cytoplasmic side of membrane-
bound vesicles [32, 33] and is present between the IMV and
EEV membranes of IEV and CEV/EEV. B5 and F13 are both
required for efficient IEV wrapping [34–36]. However, they
also associate with cellular vesicles during their transport to
the site of wrapping. B5 and F13 take different routes to the
site of wrapping [37]. For B5 this involves exocytosis to the
cell surface followed by recycling by endocytosis [38, 39].
To quantify and compare the movement of IEV of different
mutant viruses, we generated recombinant viruses in which
both capsids and IEV membranes were labelled with fluores-
cent proteins. No detrimental effect of tagging F13 with GFP
to its C-terminus has been reported [9, 28]. Considering that
a double fluorescent virus expressing mCherry-tagged A5
and GFP-tagged F13 has been described and used to charac-
terize the steps involved in EEV entry [40], a similar strategy
was used here to introduce F13 fused to mCherry (F13mC)
into viruses already expressing A5GFP. This study reports
that viruses expressing F13mC undergo aberrant wrapping
that results in reduced virus egress and spread, which are
particularly evident in viruses lacking A36.
RESULTS
Imaging of two-colour fluorescent IEVs using a
transfection/infection protocol
To generate fluorescent IEVs, F13 was tagged at its
C terminus with the mCherry fluorescent protein (F13mC)
using the same strategy as described for GFP [28]. A plas-
mid was constructed carrying the F13L orf fused to the
mCherry gene, flanked by 350 bp of both upstream (includ-
ing the F13 promoter region) and downstream sequence
from the VACV WR F13L locus. This plasmid [or an empty
vector (EV) control] was transfected into cells for 12 h and
subsequently cells were infected with VACV expressing
A5GFP (vA5GFP) [41]. The expression of F13mC from this
plasmid (pF13mC) and WT F13 from vA5GFP were ana-
lysed at different times post-infection (p.i.) by SDS-PAGE
and immunoblotting (Fig. 1a). F13 (37 kDa) is a late protein
[32] and was only detected from 6 h p.i. onwards. F13mC
(~66 kDa) was expressed with similar kinetics and at similar
levels to WT F13, suggesting that this transfection/infection
approach did not result in over-expression of F13mC.
Expression of F13mC in cells infected with vA5GFP should
result in the formation of double-labelled IEVs, with
A5GFP in the core of all virions and F13mC in the outer
membranes of IEVs, enabling these virions to be analysed
by live-cell microscopy. To test this, HeLa cells were trans-
fected with pF13mC and infected with vA5GFP and imaged
between 8 and 10 h p.i. (see Videos S1–S4, available in the
online Supplementary Material). After optimization of
acquisition settings, each cell could be imaged for a total of
20min before photobleaching of the mCherry signal. GFP
+vemCherry –ve IMVs, GFP+vemCherry+ve IEVs and
GFP-ve mCherry+ve subcellular vesicles could all be seen
moving around the infected cell. Several IEVs trafficking
from the site of wrapping to the cell periphery could be
tracked. The imaging was repeated using A5GFP viruses
defective for the expression of A36 (vDA36-A5GFP), F12
(vDF12-A5GFP) [23] or both (vDA36DF12-A5GFP) [42]. In
all samples, viral factories (Fig. 1b, perinuclear green struc-
tures) and sites of wrapping (Fig. 1b, yellow structures
located near to the nucleus) were clearly identifiable, and
double-fluorescent virions could be imaged (Fig. 1c). In
vA5GFP-infected cells these virions were clearly motile, but
in cells infected with viruses lacking either F12 and/or A36,
motile IEVs were either absent or much reduced. Although
immunoblotting showed comparable levels of F13 and
F13mC during infection (Fig. 1a), imaging of individual
cells showed highly variable levels of F13mC expression.
Notably, cells expressing very high levels of F13mC dis-
played an aberrant morphology or showed evidence of
membrane blebbing (for an example see the F13mC-
expressing cell at the left-hand edge of Video S1). The low
number of trackable virions, the heterogeneity of F13mC
expression and the apparent toxicity of F13mC at high levels
made this approach unsuitable for the quantitative compari-
son of IEV movement. Therefore, recombinant viruses
expressing both A5GFP and F13mC from their endogenous
viral promoters were constructed as an alternative
approach.
Construction and analysis of double-fluorescent
recombinant viruses
The F13mC plasmid was used to rescue a virus lacking F13
(vDF13) that is defective in virus spread and produces a
very small plaque [36, 43]. Introducing F13mC into vDF13
by homologous recombination resulted in a considerable
increase in plaque size and such viruses expressing F13mC
(vF13mC) were isolated easily.
Generating double-fluorescent viruses using pF13mC and
the various A5GFP-expressing viruses would not result in
Carpentier et al., Journal of General Virology
2
Downloaded from www.microbiologyresearch.org by
IP:  131.111.184.102
On: Wed, 04 Oct 2017 15:10:28
plaque size rescue. Therefore transient dominant selection
(see the Methods section) was used to introduce F13mC into
vA5GFP, vDA36-A5GFP and vDF12-A5GFP. Two rounds of
plaque purification in the presence of mycophenolic acid
(MPA) of GFP+ve andmCherry +ve viruses resulted in inter-
mediate EcoGPT-expressing viruses in which a single recom-
bination event had inserted the whole F13mC plasmid into
the F13 locus. All of these intermediates had similar plaque
sizes to their parental virus. MPA selection was then removed
and GFP+ve and mCherry+ve viruses produced using parent
virus vA5GFP (to produce vGmC) or vDF12-A5GFP (to pro-
duce vDF12-GmC) yielded clones that had resolved and
excised the EcoGPT cassette. However, the viruses generated
from vDA36-A5GFP did not resolve and had not lost the
EcoGPT cassette (Fig. 2a), even after additional rounds of
plaque purification. To force this resolution an EcoGPT+ve
vDA36 intermediate was passaged in D98-OR cells (HGPRT
negative) in the presence of 6-thioguanine to inhibit
the replication of EcoGPT-expressing viruses. When the
resulting progeny were plated onto fresh cell monolayers,
two distinct plaque size phenotypes were seen. Viruses
expressing WT F13 produced plaques of similar size to the
parental virus (Fig. 2b, large green plaque), while viruses that
had resolved to express F13mC produced tiny plaques
(Fig. 2b small yellow plaque).
Suspecting that a detrimental mutation had been intro-
duced into this virus, the process was repeated by inde-
pendent transfection/infection. However, this also yielded
a tiny plaque phenotype that was GFP- and mC-positive,
suggesting that F13mC was detrimental to virus spread in
the absence of A36. To confirm that this defect was due
to the mCherry tagging of F13, and not some other off-
target mutation, a revertant virus was constructed by
replacing the F13mC allele in vDA36-GmC with a WT
F13 allele to produce a vDA36-A5GFP revertant. This res-
cued the plaque size back to that of the parental vDA36-
A5GFP.
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Fig. 1. Imaging A5GFP- and F13mCherry-positive IEVs following transfection/infection. (a) F13 and F13mCherry expression in HeLa
cells. Cells were transfected with pF13mC or pSJH7 (EV) and 24 h later infected with vA5GFP at 5 p.f.u./cell. Cell lysates were prepared
at the indicated time (h) p.i. and analysed by SDS-PAGE and immunoblotting for VACV proteins F13 or D8. The positions of the molecu-
lar mass markers are indicated in kDa on the left. (b) Still images taken from movies of live HeLa cells transfected with pF13mC (red)
and infected with the indicated A5GFP (green)-expressing viruses, recorded at 8–10 h p.i. The scale bar represents 20 µm. (c) High-
magnification view of a single virion positive for both A5GFP and F13mCherry.
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The expression of F13 and F13mC in the different virus
backgrounds was examined by immunoblotting with mAb
against F13 and revealed three major bands (Fig. 2c). The
most prevalent (~38 kDa) represented F13 [32, 44]. Minor
bands were also present at 48 and 26 kDa. In viruses
expressing F13mC, three bands were detected, each corre-
sponding to one of the WT F13 bands with a ~28 kDa
mCherry protein attached to it. While the relative abun-
dance of the three bands differed slightly between WT F13
and F13mC, there was no difference in the levels of F13 or
F13mC that could explain the large plaque size reduction in
DA36 viruses.
The plaque size defect is not limited to vDA36
Viruses expressing F13 fused to GFP had not been reported
to have a plaque size defect [9, 28]. Similarly, the viruses iso-
lated here that expressed F13mC in the WT or DF12 back-
grounds had no obvious plaque size defect compared to the
parental virus. This suggested that only vDA36-GmC had a
spreading defect compared to its parent virus. A more thor-
ough analysis of the plaque size of all the viruses was under-
taken by measuring the average area of a large number of
plaques from several independent infections. This analysis
confirmed the large plaque size defect of vDA36-GmC com-
pared to both its parent and revertant viruses, but it also
revealed that the plaque size defect was not limited to
vDA36-GmC. Both vF13mC and vGmC produced plaques
that were slightly smaller than those of their respective par-
ent viruses (Fig. 3). No significant plaque size defect could
be detected for vDF12-GmC (Fig. 4). It is interesting to note
that the plaque size defect of vDA36-GmC was even more
severe than that for vDF13. In fact, the plaque size was very
similar to that produced by a virus lacking both A36 and
F12 expression [42].
The plaque size phenotype is due to reduction in
virus egress
To determine whether the reduction in the plaque size of the
F13mC-expressing viruses was due to reduced numbers of
virions reaching the cell surface, the levels of B5 on the cell
surface were measured after staining live infected cells with a
mAb to protein B5 (Fig. 5a). As reported, viruses lacking A36
or F12 had reduced, or greatly reduced, surface B5. By com-
parison, B5 was also reduced from WT levels in vGmC-
infected cells. Quantification by flow cytometry (Fig. 5b) and
direct counting of B5 positive virions (CEVs) by confocal
microscopy (Fig. 5c) confirmed these observations. Both
vGmC and vDA36-GmC showed lower surface B5 levels than
their GFP parental viruses, each resulting in about a third of
the number of virions reaching the cell surface compared to
the parental virus. The surface B5 levels measured by flow
cytometry for vDF12-GmC did not differ from those of its
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Fig. 2. Generation and analysis of GmC viruses. (a) PCR analysis of
the genomes of intermediate (I), parental (P) and recombinant VACVs.
GFP+ve and mCherry+ve plaques were selected after three rounds of
plaque purification in the absence of drug selection (R) and genomic
DNA was analysed with primers specific for the A36, F12 and EcoGPT
genes, as indicated. The sizes of the PCR products are indicated on
the left in bp. (b) Epi-fluorescence microscopy showing two plaque
phenotypes observed on BS-C-1 cells after passaging a vDA36-GmC
intermediate (EcoGPT+ve) virus through D98-OR cells in the presence
of 6-thioguanine. Viruses expressing WT F13 produced large plaques,
while viruses that expressed F13-mC produced a small plaque. Pla-
ques were imaged at 4 days p.i. The scale bar indicates 250 µm. (c)
Analysis of F13 and F13mC expression by the recombinant VACVs.
BS-C-1 cells were infected with the indicated viruses at 10 p.f.u./cell
for 16 h. Lysates of these cells were prepared and analysed by SDS-
PAGE and immunoblotting with a mAb against VACV protein F13.
The sizes of the F13 proteins are shown on the right and the positions
of the molecular mass markers are indicated on the left (kDa). The
calculated molecular mass (kDa) of the different F13 bands is indi-
cated on the right.
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parent GFP virus, and the slight reduction in the number of
surface virions counted by confocal microscopy was not sta-
tistically significant (Student’s t-test, P=0.17). Thus those
viruses that showed a plaque size reduction also showed a
defect in egress. These differences were not due to differences
in virus replication, because the yields of infectious GmC
viruses at 18 h p.i. were indistinguishable from those of their
parental A5GFP viruses (Fig. 5d).
Identification of a wrapping defect in F13mC-
expressing viruses by electron microscopy
Fewer virions reaching the cell surface could indicate a
defect in IEV formation or their transport. To investigate
this, infected cells were studied by electron microscopy
(Fig. 6). In the A5GFP viruses expressing WT F13, IMVs in
the process of being wrapped with a double-membrane
envelope, and fully wrapped IEVs were identified easily
(Fig. 6a). In viruses expressing F13mC the wrapping process
was abnormal. Some wrapping membranes failed to tightly
surround virions, resulting in large ‘bubble’-like structures
containing significant volumes of cytoplasmic material, and
some of these ‘bubbles’ enclosed multiple virions. Analysis
of samples that had been treated with a fluid-phase marker
prior to fixation showed that the membranes forming these
bubbles were of endosomal origin (Fig. 6b), indicating
they are derived from the same membrane pool as those
that form the normal IEV envelopes [7]. These aberrant
wrapping structures were found in all the F13mC-express-
ing viruses, vGmC, vDA36-GmC and vDF12-GmC. The rel-
ative abundance of different virion types was quantified by
counting the IMVs (including partially wrapped IMVs),
fully formed IEVs, aberrantly wrapped bubbles and extracel-
lular virions (including those associated with actin tails)
present in a minimum of 10 cell profiles per sample (Fig. 7).
Viruses expressing F13mC had more IMVs than enveloped
virion types, indicating a bottleneck at the point of wrap-
ping. Additionally, some of the wrapped virions were aber-
rant, forming bubbles. This wrapping defect was completely
absent from viruses expressing WT F13. Interestingly,
vDA36-GmC produced a greater proportion of these bubble
virions (compared to total virions) than either vGmC or
vDF12-GmC (Fig. 7).
DISCUSSION
This study describes the characterization of a panel of dou-
ble-fluorescent VACVs that were constructed to enable
measurement of IEV movement in cells infected with
viruses lacking either A36 or F12, proteins that are involved
in kinesin-1-mediated egress of IEV. A36 is the only protein
known to link IEVs directly to the kinesin-1 complex, but in
its absence IEV egress on MTs still occurs, albeit at reduced
efficiency [23]. In the absence of a functional F12/E2 com-
plex, A36 is unable to contribute to virus egress [42]. The
F12/E2 complex can also bind kinesin-1 via the C-terminal
region of KLC2 [26], but F12 and E2 are not integral mem-
brane proteins, and the association of F12 with IEVs was
reported to be dependent on A36 [24]. Therefore, there
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Fig. 3. Plaque size analysis of recombinant viruses. (a) BS-C-1 cells
were infected with the indicated viruses at 20–30 p.f.u./well and
stained 5 days p.i. (left column) or 2 days p.i. (right column). At 2
days p.i. a representative plaque for each virus is shown (scale
bar=500µm). b) At 2 days p.i. 30 plaques for each virus from 3 differ-
ent cell monolayers were photographed and the average area
±SEMwas calculated. The plaque sizes of F13mC-expressing viruses
were compared to those of their WT F13-expressing counterparts
using Student’s t-test (*, P<0.05; ****, P<0.0001).
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must be an alternative link between IEVs and kinesin-1 that
can mediate IEV egress in the absence of A36. The IEV
envelope incorporates several cellular proteins [45, 46] and
it is possible that one of these forms the IEV/kinesin-1 link.
Alternatively, one of the other VACV IEV membrane-asso-
ciated viral proteins, A33, A34, B5, A56 or F13, might also
do so. Most of these only have a small cytoplasmic domain,
with the majority of the polypeptide being oriented into the
membrane lumen (for a review see [47]), and a yeast-2-
hybrid screen [21] and co-immunoprecipitation screen [22]
failed to identify a direct interaction between any of these
proteins and KLCs.
To characterize IEV egress and compare the type of virion
movement that takes place when various components of the
virus trafficking complex are absent, a panel of double-fluo-
rescent viruses was generated to enable differentiation of
IEVs from other virion types in infected cells. During
the construction of viruses expressing F13 tagged with
mCherry, a plaque size defect was observed that was most
acute in the absence of A36 (Figs 2 and 3). This was due to
impaired function of the F13 protein, because restoration of
WT F13 repaired the plaque size defect (Fig. 4). The
reduction in the plaque size of F13mCherry-expressing
viruses was accompanied by a reduction in the number of
virions reaching the cell surface (Fig. 5), suggesting a defect
in either the formation or transport of IEVs. Electron
microscopy revealed that F13mC caused aberrant wrapping
of IMVs by intracellular membranes, and this defect was
apparent in all viruses expressing F13mC, not just viruses
lacking A36 (Figs 6 and 7).
F13 is essential for the wrapping process that results in the
formation of IEVs [36], and drugs that target F13, such as
IMCBH [47] and ST-246 [48], inhibit this wrapping pro-
cess. The VACV B5 protein is also required for IEV wrap-
ping [34, 35], although only its transmembrane domain and
a small part of its lumenal domain are essential [49–51].
Viruses in which one or more of the B5 SCR domains are
deleted produce IEVs that are transported to the cell surface
but are released more easily, resulting in increased EEV [49,
52]. Herrera et al. [49] described IEVs (visualized by EM)
with loosely attached envelopes that are similar to the bub-
ble virions described here. However, these differ in that the
B5 mutations disrupt the interaction between the inner and
outer IEV envelopes, resulting in virions with additional
2.5 NS
NS
(b)
(a)
v∆A36
v∆A36-A5GFP
v∆A36-GmC
v∆F13
v∆F12-GmC
v∆F12
v∆F12-A5GFP
v∆A36∆F12
A5GFP
v∆A36-A5GFP
revertant
9 days p.i.
***
****
2.0
1.5
P
la
q
u
e
 s
iz
e
 (
m
m
2
)
1.0
0.5
0
v∆
A3
6
v∆
A3
6-
A5
G
FP
v∆
A3
6-
G
m
C
v∆
A3
6-
A5
G
FP
 (r
ev
)
v∆
A3
6∆
F1
2-
A5
G
FP
v∆
F1
2
v∆
F1
2-
A5
G
FP
v∆
F1
2-
G
m
C
v∆
F1
3
Fig. 4. Plaque size analysis of recombinant viruses. (a) BS-C-1 cells were infected with the indicated viruses at 20–30 p.f.u./well and
plaques were stained and photographed 9 days p.i. (scale bar=500 µm). (b) Plaque sizes were measured as described for Fig. 3b. The
plaque sizes of viruses lacking A36 or F12 were compared using one-way ANOVA with Tukey’s multiple comparison test (NS, non-sig-
nificant; ***, P<0.001; ****, P<0.0001). A virus lacking F13 expression (vDF13) is included for comparison.
Carpentier et al., Journal of General Virology
6
Downloaded from www.microbiologyresearch.org by
IP:  131.111.184.102
On: Wed, 04 Oct 2017 15:10:28
800 ****
*
NS
600
400
200
0
12 500(b)
(a)
(c) (d) 7 NS NS NS
6
5
4
3
2
1
0
vGFP
vGmC
v∆F12-GFP
NS
v∆F12-GmC
v∆A36-GFP
v∆A36-GmC
Isotype control
*
**
10 000
S
u
rf
ac
e
 B
5
 in
te
n
si
ty
(M
F
I/
c
e
ll)
S
u
rf
ac
e
 v
ir
io
n
s/
c
e
ll
p
fu
/s
am
p
le
 (
lo
g
1
0
)
7500
5000
2500
0
0 4 8
h p.i.
12 16
vG
FP
vG
m
C
v∆
A3
6-
G
FP
v∆
A3
6-
G
m
C
v∆
F1
2-
G
FP
v∆
F1
2-
G
m
C
vG
FP
vG
m
C
v∆
A3
6-
G
FP
v∆
A3
6-
G
m
C
v∆
F1
2-
G
FP
v∆
F1
2-
G
m
C
GFP Surface B5
Fig. 5. Egress assay comparison of recombinant viruses. (a) Confocal laser scanning microscopy of BS-C-1 cells infected with the
indicated viruses. At 8 h p.i. live cells were stained with mAb for VACV protein B5 (red). The images are maximum-intensity projections
of z-stack-acquired images encompassing the entire volume of the cell showing the A5GFP signal (green, virus capsids) and the sur-
face B5 staining (magenta). Scale bars=20µm. (b) Levels of B5 on the surface of BS-C-1 cells treated as for (a) at the indicated times
p.i. and analysed by flow cytometry. The values shown are the mean fluorescence intensities (MFI) of a minimum of 2500 events. The
isotype control represents vGmC-infected cells stained with a mAb to an intracellular VACV epitope not exposed on the CEV surface
(see the Methods section). The graph shown is representative of three independent experiments. The egress levels at 16 h p.i. for each
of the GmC viruses were compared to those of the A5GFP parental virus using Student’s t-test (NS, non-significant; *, P<0.05;
**, P<0.01). (c) BS-C-1 cells were infected and treated as in (a) and at 12 h p.i. the number of CEV particles (B5+ve, GFP+ve) on the cell
surface were counted. The values shown are the averages of a minimum of 12 cells (4 each from 3 independently infected and stained
coverslips) +SD and are representative of 2 independent experiments. The values for each GmC virus were compared to those of the
A5GFP parental virus using Student’s t-test (NS, non-significant; *, P<0.05; ****, P<0.0001). (d) Virus replication. BS-C-1 cells
were infected at 10 p.f.u./cell and 18 h later the total virus yield was titrated by plaque assay on BS-C-1 cells. Triplicate infections
were carried out for each virus. The average titre per sample is shown +SD. Each GmC sample was compared statistically to its A5GFP
parent by a linked Student’s t-test (NS, non-significant).
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(a)
(b)
Fig. 6. Analysis of virus wrapping by electron microscopy. (a) HeLa cells were infected with the indicated viruses at 5 p.f.u./cell and at
16 h p.i. were processed for transmission electron microscopy. Comparison of A5GFP viruses, where wrapping membranes and IMVs
are tightly apposed, and GmC viruses, where wrapping membranes are less tightly associated with virions forming large enclosed
bubble-like structures containing extra cytoplasmic material. Scale bars=100 nm. (b) Transmission electron microscopy of vGmC-
infected cells treated with a liquid-phase marker for 60min. The dark staining of the lumen between membranes (indicated by white
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lumenal material. In contrast, in the F13mC virus the outer
and inner IEV envelopes remain tightly apposed (see Fig. 6)
and it is the interaction between the inner IEV envelope and
the IMV surface that is disrupted, resulting in virions carry-
ing additional cytoplasmic material.
It is intriguing that the same wrapping defect found in all
three GmC viruses described in this study leads to such dif-
ferent changes in plaque size. A similar situation was
described in which the expression of a GFP-tagged full
length B5 protein produced a defect that was only detectable
in a virus lacking expression of A33 [53]. Both A36 and F13
are associated with the membranes that wrap around IMVs
and are oriented into the cytoplasm. During wrapping, A36
is excluded from the space between the IMV and the inner
wrapping membrane and accumulates on what becomes the
outer IEV membrane [19]. It is possible that this exclusion
occurs simply because A36 is being squeezed out as F13
interacts with the IMV surface. The defect in wrapping in
the presence of F13mC might simply be steric, in that there
is no room for F13mC to interact normally with the IMV
surface and the zippering up of the interaction between the
wrapping membranes and IMV is hindered by this bulky
addition to F13. It is also possible that A36 is somehow
involved in this process. Although A36 is not required for
wrapping, its presence may somehow enhance the F13–
IMV interaction. This could explain the higher prevalence
of bubbles observed in the vDA36-GmC virus, but cannot
satisfactorily explain the severe plaque size defect.
Excluding A36, only F13 is located entirely within the cyto-
plasm, making it a good candidate to form the alternative
link between IEVs and kinesin-1. Large protein tags such as
mCherry can potentially interfere sterically with protein–
protein interactions. If F13 was the alternative link between
IEVs and kinesin-1, then anything that interfered with the
establishment of this link might induce a larger defect when
A36 is absent compared to when it is present, just as was
observed for plaque size. However, both vGmC and vDA36-
GmC show a similar reduction (60–70%, Fig. 5c) in the
number of virions that reach the cell surface. Thus, the most
plausible explanation for the severe plaque size defect of
vDA36-GmC is the contribution of A36-mediated actin tail
formation in virus spread. Actin tail formation enhances the
ability of virions to contact neighbouring cells [54], thus low-
ering the number of virions required at the cell surface to
guarantee spread. Therefore, a reduction in virus egress will
have a much larger impact on plaque size when actin tails are
absent compared to when they are present. Furthermore,
proteins A36 and A33, which are needed for actin tail forma-
tion, also induce actin tails underneath superinfecting viri-
ons, thereby enhancing virus spread further [55, 56]. These
are the reasons why vDF12-GmC (which has a functional
A36) has far fewer virions reaching the cell surface than
vDA36-GmC but produces significantly larger plaques. Simi-
larly, it was recently reported that disruption of F12 caused a
larger plaque size defect when A36-mediated actin tail for-
mation (but not A36-mediated kinesin-1 recruitment) was
disrupted compared to when A36 was fully functional [42].
In summary, this paper reports that the addition of a fluo-
rescent protein onto the C terminus of the F13 protein
causes a defect in the wrapping of IMVs to form IEVs.
The IEVs that are formed have less tightly attached outer
membranes, larger volumes of cytoplasm between the IMV
and IEV membranes, and often more than one IMV particle
wrapped within the IEV membranes. This defect causes
arrows) associating with virions (open arrows) reflects their endosomal origin. Stained tubular endosomes are indicated by filled
arrows in the middle panel. The panel on the right is a magnified view of the wrapping event shown in the middle panel.
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Fig. 7. Quantitation of different virion types by electron microscopy.
The different virion types identified in electron micrographs produced
by the various A5GFP and GmC viruses were quantified. Between 472
and 1200 virions were counted for each virus from a minimum of 10
complete cell profiles per sample. The percentage of IMVs, IEVs (par-
tially or completely wrapped) ‘bubbles’ (IMV enclosed within loosely
associated wrapping membranes) and released extracellular virions is
shown. vDF13 is included as a control virus unable to form IEVs.
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reduced transport of virions to the cell surface and reduced
spread from cell to cell. Therefore, although the attachment
of fluorescent proteins to F13 has been reported as a strat-
egy to visualize IEV movement [9, 28, 40, 57, 58], it is
important to recognize this could affect virus wrapping and
transport. While the data presented here, which show
that the fusion of mCherry to F13 results in a wrapping
defect, should not automatically be extrapolated to other
F13 fluorescent tagging strategies, it should be noted that
EGFP and mCherry are very similar in size (239 versus 236
amino acids) and pI (5.58 versus 5.62), and have similar
protein folds. Minor defects have been reported for some
viruses expressing a GFP-tagged F13. Specifically, in a study
by Geada et al. [9] a spreading defect is described that was
most apparent in the VACV IHD-J strain. Therefore, while
these viruses are useful tools for tracking VACV virions,
they are imperfect reagents and so data should be inter-
preted cautiously.
METHODS
Plasmids
A DNA fragment encompassing the F13 orf along with
376 bp of upstream sequence was amplified by PCR from
VACV genomic DNA using oligonucleotides F13UPF1 (5¢-
caccgaattc cgtattggac atgcttatgt acgtag-3¢) and F13R1 (5¢-
cttgtacagg atccgctagc ccaattttta acgatttact gtggctagat acc-3¢).
A fragment encompassing the F13 stop codon and 376 bp of
downstream sequence was amplified with oligos F13DNF1
(5¢-gctagcggat cctgtacaag taaaaaaaag aaaatagaga cgtatagaac
gc-3¢) and F13DNR1 (5¢-caccaagctt ctccctgttc gtgggaacgc-
3¢). The two fragments were spliced together using splicing
by overlap extension [59] to generate a fragment encoding
the F13 orf with recognition sequences for the NheI, BamHI
and BsrGI restriction enzymes introduced just before the
F13 stop codon. This fragment was inserted into the EcoRI-
HindIII restriction sites of pSJH7, a pUC13 plasmid
expressing the Escherichia coli guanine phosphoribosyl-
transferase (Ecogpt) gene from the VACV 7.5K promoter
[60] to produce pSJH7-F13. Subsequently the NheI-BsrGI
restriction fragment encoding the mCherry protein was
subcloned from pUC13-EcoGPTmCherry [26] into the
NheI-BsrGI sites introduced before the F13 stop codon to
generate plasmid pSJH7-F13mCherry (pF13mC).
Cell culture and virus propagation
RK-13 cells (rabbit kidney cell line, ATCC CCL-37) were
maintained in minimal essential medium (Gibco) supple-
mented with 10% foetal bovine serum (FBS) and penicillin–
streptomycin (Pen/Strep, Gibco). HeLa cells (human cervix
adenocarcinoma, ATCC CCL-2) were maintained in mini-
mal essential medium supplemented with 10% FBS, non-
essential amino acids and Pen/Strep (Gibco 11140). D98-
OR, a hypoxanthine phosphoribosyl transferase-deficient
HeLa cell-line [61], CV-1 (African green monkey cell line,
ATCC CCL70) and BS-C-1 (African green monkey cell line,
ATCC CCL-26) cell lines were maintained in Dulbecco’s
modified Eagle’s medium (Gibco) supplemented with 10%
FBS and Pen/Strep.
All of the viruses used in this study were amplified in RK-13
cells and titrated by plaque assay on BS-C-1 cells using a
carboxymethyl cellulose overlay. A recombinant virus in
which the F13L gene has been disrupted by insertion of the
EcoGPT gene was a kind gift from Bernard Moss (NIH,
NIAID, Bethesda, Maryland, USA) [36]. VACV expressing
GFP fused to the A5 capsid protein, WT (vA5GFP) [27], as
well as viruses lacking expression of F12 (vDF12-A5GFP),
A36 (vDA36-A5GFP) [23], or both (vDA36DF12-A5GFP)
[42] have been described.
Imaging double-fluorescent IEVs using infection/
transfection
HeLa cells seeded into six-well plates were transfected with
pF13mC using the Transit-LT1 transfection reagent (Mirus
Bio LLC) and 16 h later were infected with vA5GFP at 2 p.f.
u./cell. Infected cells were lysed in PBS with 1%NP-40 and
insoluble material was removed by centrifugation (15 000 g,
15 min, 4

C). Clarified lysates were analysed by SDS-PAGE
and immunobloting using rat mAb 15B6 that recognises
VACV protein F13 [6] and mouse mAb AB1.1 that recog-
nises VACV protein D8 [14]. The blots were probed with
IRDye-conjugated secondary antibodies (LI-COR) and
imaged using a LI-COR Odyssey scanner.
To estimate whether IEVs could be labelled with
F13mCherry, HeLa cells were seeded at low density in glass-
bottomed tissue culture dishes (MatTek), and transfected
and infected as described above. The cells were then imaged
between 8 and 10 h p.i. using a Zeiss LSM780 confocal laser
scanning microscopy system mounted on an AxioObserver.
Z1 inverted microscope with a 64 Plan Apochromat
objective (NA; 1.4) and Zen (Zeiss) acquisition software.
Each cell was imaged for a total of 2 min at a rate of 0.5
frames s 1.
Construction and characterization of recombinant
viruses
VACV expressing F13mC were generated by transient dom-
inant selection [62]. CV-1 cells were infected with vA5GFP,
vDF12-A5GFP or vDA36-A5GFP at 0.1 p.f.u./cell and
subsequently transfected with pF13mC using TransIT-LT1
(Mirus Bio LLC). The resulting viruses were selected by
three rounds of plaque purification in the presence of myco-
phenolic acid, xanthine and hypoxanthine to select for
EcoGPT expressing intermediate viruses that had incorpo-
rated the pF13mC plasmid. GFP+ve and mCherry+ve
viruses were then plaque-purified three additional times
without drug selection. PCR using oligos EcogptDCF1 (5¢-
cgtcacctgg gacatgttg-3¢) and EcogptDCR1 (5¢-gacgaatacg
acgcccatat c-3¢), producing a PCR product of 421 bp when
the EcoGPT cassette is present, was used to identify isolates
that had undergone a second recombination event, remov-
ing the EcoGPT cassette along with the WT F13 allele. PCR
using primers F12ForDC1 (5¢-atgttaaaca gggtacaaat
cttgatga-3¢) and F12RevDC1 (5¢-catctttgat ctcgatggaa tgca-
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3¢), giving a ~2-kbp fragment for a WT allele and a ~800-
bp fragment for the DF12 allele, was used to confirm the
identity of the F12 allele in each of the viruses. PCR using
primers DCA36SeqF1 (5¢-gcgtataacc tgtatacagc tgg-3¢) and
DCA36SeqR1 (5¢-accgtttcat ccatctgtct attg-3¢), giving a
1085-bp fragment for a WT A36 allele and a 658-bp frag-
ment for the DA36 allele, was used to confirm the identity
of the A36 allele in each of the viruses. This process failed to
identify a A5GFP+ve, F13mCherry+ve, EcoGPT –ve
vDA36. For this virus, negative selection was used to enrich
for recombinants that had lost the EcoGPT cassette. The
intermediate vDA36 virus was used to infect D98-OR cells
at low m.o.i. in the presence of 6-thioguanine, which is toxic
when EcoGPT is present. The resulting GFP+ve, mCherry
+ve, EcoGPT –ve viruses were isolated by three additional
rounds of plaque purification on BS-C-1 cells without drug
selection. To generate a vDA36-A5GFP revertant virus, the
process described above was repeated, infecting with
vDA36-GmC and transfecting with pSJH7-F13.
Expression of F13mCherry by all recombinant viruses was
assessed by SDS-PAGE and immunoblotting as described
above. The plaque size produced by the various recombi-
nant viruses was assessed by standard plaque assay on BS-
C-1 cells. Briefly, monolayers of BS-C-1 cells in six-well
plates were infected with 20–30 p.f.u./well. After 1 h of infec-
tion the inoculum was replaced with an overlay containing
1.5% carboxymethyl cellulose. Cells were incubated at 37

C
for 2 to 9 days (until plaques could be visualized and were
large enough to measure). Cells were fixed and stained with
crystal violet solution (0.115% crystal violet and 0.005
ammonium oxalate in 25% v/v ethanol). Plaques were
imaged using an AxioObserver.Z1 inverted microscope. Pla-
que surface area was measured using AxioVision (release
4.8) software. A minimum of 15 measurements from 3 inde-
pendent wells (for a total of 45 measurements) were used to
carry out statistical analysis using the statistical software
package GraphPad Prism (version 5.04).
Analysis of virion egress by surface B5 staining
To determine the efficiency of virus egress, the number of
virions on the cell surface was measured by surface staining
for the CEV/EEV surface protein B5 as described [23].
Briefly, sub-confluent BS-C-1 cells seeded in 24-well plates
(for flow cytometry) or onto poly-D-lysine-coated coverslips
in 12-well plates (for microscopy) were infected at 5 p.f.u./
cell. At the time of sample collection, cells were placed on ice
and the medium was replaced for 45 min with fresh pre-
cooled medium (DMEM 2.5% FBS) containing the rat mAb
19C2 [6] that recognizes the VACV B5 protein. The rat mAb
15B6 [6] that recognizes F13 was used as a negative control.
For analysis by flow cytometry, the medium was replaced by
fresh pre-cooled medium containing a goat anti-rat IgG
Alexa Fluor 647-conjugated secondary antibody (Life Tech-
nologies) for 45 min on ice. Subsequently, cells were dissoci-
ated using AccuEasy cell-lift solution (Biotium) and fixed
with 4% paraformaldehyde. Surface B5 staining levels were
measured using a Becton Dickinson Cytek FACScan DxP8
and analysed using MoFlo software. Statistical analysis of
triplicate samples was carried out using GraphPad Prism.
For manual counting of the number of surface virions by
confocal microscopy, B5-stained infected cells on glass cov-
erslips were fixed with 4% paraformaldehyde in 250mM
HEPES pH 7.5 for 10 min on ice followed by 8% parafor-
maldehyde (250mM HEPES pH 7.5) for 20 min at room
temperature. B5 staining was detected using a goat anti-rat
IgG Alexa Fluor 546-conjugated secondary antibody (Life
Technologies). Slides were mounted (10%w/v Mowiol4–88
(CalBiochem), 25% v/v glycerol, 100mM Tris-HCl pH 8.5,
0.5 µgml 1 DAPI (4’,6-diamidino-2-phenylindole; Sigma)
and imaged using a Zeiss LSM780 confocal laser scanning
microscopy system mounted on an AxioObserver. Z1
inverted microscope using a 64 Plan Apochromat objec-
tive (NA; 1.4) and Zen (Zeiss, 2011 version) acquisition
software. Z-stacks encompassing the full volume of the cell
were acquired and used to generate maximum fluorescence
intensity projections down the z-axis. Images were proc-
essed and analysed using Zen, ImageJ and Photoshop
(Adobe) software.
Electron microscopy
For the analysis of virus wrapping by EM sub-confluent,
HeLa cells were infected at 5 p.f.u./cell. For labelling with a
fluid phase marker, cells were incubated with 10mgml 1
horseradish peroxidase (HRP) dissolved in cell culture
medium for 1 to 2 h prior to fixation. At 8–10 h p.i. cells
were fixed in 0.5% glutaraldehyde (200mM sodium cacody-
late pH 7.4) for 30min and washed in 200mM sodium
cacodylate. For visualization of HRP, samples were reacted
with a metal-enhanced DAB substrate kit (Thermo Scien-
tific) for 30min. All samples were postfixed (1% osmium
tetroxide, 1.5 % potassium ferrocyanide) for 60min at room
temperature. Cells were washed in water, incubated in 0.5%
magnesium-uranyl acetate overnight at 4

C, washed again
in water, dehydrated in ethanol and embedded flat in Epon.
Sections were cut parallel to the surface of the dish and col-
lected onto slot grids. Lead citrate was added for contrast.
Images were acquired using a CCD camera mounted on a
FEI Tecnai G2 transmission electron microscope.
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